Skip to main content

Information to ESRF users


The ESRF wishes to inform the User Community that the operation of the ID17 Biomedical Beamline is suspended. A few experiments are still scheduled until July 2023; but no further ID17 operation is planned from August 2023.

  • Share

The decision to halt ID17 operation is adopted in the context of the latest ESRF investment strategy review, and is linked to the outcome of the recent (2022) beamline review, which requests further investment to refocus the ID17 science case in the medium- to long-term.

The future science case of the ID17 beamline will be discussed and streamlined at a dedicated workshop planned for later this year.  With the objective to identify a consequent beamline refurbishment plan in 2023, a preliminary resource loaded schedule foresees beamline works in the 2025-2026 period, and a user operation that could restart in 2027.